Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bionetide in Rett Syndrome
NCT06840496Phase 3Recruiting
- Sponsor
- Biomed Industries
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Bionetide in Rett syndrome (RTT), sponsored by Biomed Industries. Started Sep 2026; status: recruiting.
02
Drugs
Bionetide
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT06840496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06840496.